BioLineRx names new board member
This article was originally published in Scrip
Executive Summary
Jerusalem-based biopharmaceutical company BioLineRx, which is focused on in-licensing and developing therapeutic candidates, has named Dr Sandra Panem to its board of directors – effective from 24 February 2014. Dr Panem is currently a managing partner at Cross Atlantic Partners and is on the board of directors for Acorda Therapeutics, GenomeQuest, Labcyte, and MDx Medical.